A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) (clinicaltrials.gov) - Mar 23, 2023 - P2b | N=279 | Not yet recruiting | Sponsor: Kezar Life Sciences, Inc.
New P2b trial • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|